This inventor holds 3 USPTO granted patents. Top assignee: The Dow Chemical Company. Active years: 1978-1982.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Midland, MI (US) (1978)
- Indianapolis, IN (US) (1982)
Company Filing History:
Years Active: 1978-1982
Title: Jimmie L Moore: Innovator in Pharmaceutical Chemistry
Introduction
Jimmie L Moore is a notable inventor based in Midland, MI (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the treatment of central nervous system conditions. With a total of 3 patents, his work has garnered attention for its innovative approaches and potential applications.
Latest Patents
Among his latest patents is a method and compositions for the treatment of central nervous system depression in mammals. This involves the use of 1-aryl-1,2,3,4-tetrahydro-.beta.-carboline-3-carboxylic acids, esters, and pharmaceutically-acceptable salts. Another significant patent is for N,15-Didehydro-15-deoxo-pyrimidino-(4,5-b)rifamycin S, which is prepared through an activated manganese dioxide oxidation process. This new compound has demonstrated antimicrobial utility, showcasing the breadth of his research.
Career Highlights
Jimmie L Moore is currently associated with The Dow Chemical Company, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a commitment to advancing medical treatments and improving patient outcomes.
Collaborations
Throughout his career, Jimmie has collaborated with esteemed colleagues, including James R McCarthy, Jr and Alan J Payne. These partnerships have contributed to the success of his projects and the advancement of their shared goals in pharmaceutical research.
Conclusion
Jimmie L Moore stands out as a dedicated inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various medical conditions. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
